Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to 0.17%.

  • Angiodynamics' Return on Capital Employed rose 10000.0% to 0.17% in Q4 2025 from the same period last year, while for Nov 2025 it was 0.17%, marking a year-over-year increase of 10000.0%. This contributed to the annual value of 0.18% for FY2025, which is 4000.0% up from last year.
  • As of Q4 2025, Angiodynamics' Return on Capital Employed stood at 0.17%, which was up 10000.0% from 0.18% recorded in Q3 2025.
  • Angiodynamics' 5-year Return on Capital Employed high stood at 0.01% for Q3 2023, and its period low was 1.17% during Q4 2024.
  • Over the past 5 years, Angiodynamics' median Return on Capital Employed value was 0.1% (recorded in 2022), while the average stood at 0.27%.
  • Per our database at Business Quant, Angiodynamics' Return on Capital Employed plummeted by -11500bps in 2024 and then surged by 10000bps in 2025.
  • Over the past 5 years, Angiodynamics' Return on Capital Employed (Quarter) stood at 0.08% in 2021, then increased by 19bps to 0.07% in 2022, then soared by 73bps to 0.02% in 2023, then plummeted by -6133bps to 1.17% in 2024, then soared by 86bps to 0.17% in 2025.
  • Its Return on Capital Employed was 0.17% in Q4 2025, compared to 0.18% in Q3 2025 and 0.19% in Q2 2025.